A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination.

Autor: Oliveira RD; Curso de Enfermagem, Universidade Estadual de Mato Grosso do Sul, Dourados, MS, Brazil; Programa de Pós-graduação em Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, MS, Brazil., Santos ADS; Faculdade de Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, MS, Brazil., Gonçalves CCM; Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil; Secretaria Estadual de Saúde de Mato Grosso do Sul, Campo Grande, MS, Brazil., Giovanetti M; Department of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Italy; Instituto René Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil., Alcantara LCJ; Instituto René Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil., Demarchi LHF; Laboratório Central de Saúde Pública, Campo Grande, MS, Brazil., Lichs GGC; Laboratório Central de Saúde Pública, Campo Grande, MS, Brazil., Ilis TM; Laboratório Central de Saúde Pública, Campo Grande, MS, Brazil., Hiane ST; Laboratório Central de Saúde Pública, Campo Grande, MS, Brazil., Abbud A; Instituto Adolfo Lutz, São Paulo, SP, Brazil., Sacchi CT; Instituto Adolfo Lutz, São Paulo, SP, Brazil., Naveca FG; Fundação Oswaldo Cruz, Rio de janeiro, RJ, Brazil., Santos DS; Secretaria Municipal de Saúde de Dourados, Dourados, MS, Brazil., Marques EMM; Secretaria Municipal de Saúde de Dourados, Dourados, MS, Brazil., Lucena Junior WP; Secretaria Municipal de Saúde de Dourados, Dourados, MS, Brazil., Croda J; Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil; Fundação Oswaldo Cruz - Mato Grosso do Sul, Campo Grande, MS, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. Electronic address: julio.croda@fiocruz.br.
Jazyk: angličtina
Zdroj: Travel medicine and infectious disease [Travel Med Infect Dis] 2024 Oct 24; Vol. 62, pp. 102782. Date of Electronic Publication: 2024 Oct 24.
DOI: 10.1016/j.tmaid.2024.102782
Abstrakt: Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Julio Croda reports a relationship with Takeda Pharmaceutical Company Limited that includes: funding grants, honoraria to participate in the Global Steering Committee and Brazilian Advisory Boarding. Roberto Dias de Oliveira reports a relationship with Takeda Pharmaceutical Company Limited that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze: MEDLINE